These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1950 related items for PubMed ID: 31361869

  • 21. Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Elias AM, Pepin MJ, Brown JN.
    J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
    [Abstract] [Full Text] [Related]

  • 22. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY.
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE, Tompkins DA, Bigelow GE, Strain EC.
    JAMA Psychiatry; 2017 Sep 01; 74(9):885-893. PubMed ID: 28700791
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B, Williams AR, Chemi C, Suhail-Sindhu S, Dickson V, Lee JD.
    Subst Use Misuse; 2019 Sep 01; 54(14):2409-2419. PubMed ID: 31429351
    [Abstract] [Full Text] [Related]

  • 30. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
    Andraka-Christou B, Nguyen T, Harris S, Madeira J, Totaram R, Randall-Kosich O, Atkins D, Ford J.
    Am J Drug Alcohol Abuse; 2020 Sep 02; 46(5):589-603. PubMed ID: 32543922
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B, Gilmour J, Deering D.
    Int J Ment Health Nurs; 2019 Feb 02; 28(1):226-236. PubMed ID: 30019812
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
    Hadland SE, Bagley SM, Rodean J, Silverstein M, Levy S, Larochelle MR, Samet JH, Zima BT.
    JAMA Pediatr; 2018 Nov 01; 172(11):1029-1037. PubMed ID: 30208470
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 98.